|
May 3
|
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
|
|
May 2
|
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
|
|
Apr 22
|
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
|
|
Apr 16
|
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
|
|
Apr 9
|
Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
|
|
Mar 30
|
Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.
|
|
Mar 26
|
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Mar 13
|
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
|
|
Mar 9
|
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
|
|
Mar 4
|
Analysts Just Made A Major Revision To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Forecasts
|
|
Feb 21
|
Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast
|
|
Feb 20
|
Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research
|
|
Jan 5
|
Voyager Therapeutics Announces Pricing of Public Offering
|
|
Jan 4
|
Voyager Therapeutics Announces Proposed Public Offering
|
|
Jan 4
|
Biotech Stock Roundup: VYGR Gains From NVS Deal, AGIO Up on Study Data & More
|
|
Jan 2
|
UPDATE 2-Novartis signs gene therapy deal with Voyager for $100 mln upfront
|
|
Jan 2
|
Voyager Therapeutics shares jump after $1.2 billion deal with Novartis
|
|
Jan 2
|
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies
|
|
Dec 8
|
12 Best Healthcare Stocks For the Long-Term
|
|
Dec 6
|
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
|